<p>This disclosure describes methods that generally include administering to an immune compromised subject an amount of a lymphotoxinβreceptor (LTβR) agonist effective to increase immune function in the subject compared to a suitable control immune compromised subject. In some cases, the method can result decreasing the period of immune deficiency in the subject compared to a suitable control immune compromised subject.</p>
申请公布号
EP2903642(A1)
申请公布日期
2015.08.12
申请号
EP20130783724
申请日期
2013.10.04
申请人
REGENTS OF THE UNIVERSITY OF MINNESOTA;SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
发明人
BLAZAR, BRUCE, R.;STEFANSKI, HEATHER, E.;WARE, CARL F.